This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Introduction/Focus on Panic Disorder: Antidepressants in Practice

 

Published: January 1, 1998

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Panic disorder is a prevalent, chronic, and disabling condition that has a considerableimpact on quality of life. Etiologic models postulate dysfunction in several brain neurotransmitters, although increasing prominence is given to the role of serotonin. The developmentof antidepressants with specific serotonergic activity has facilitated the recognitionof effective therapies.What defines clinical improvement and treatment response in panic disorder?


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...